Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
5726
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $58K | ﹤0.01% |
1,200
-5,000
| -81% | -$261K |
|
|
XONE
5727
CALL
DELISTED
The ExOne Company
XONE
| $58K | ﹤0.01% |
6,500
+3,600
| +124% | +$29.4K |
|
|
FLNT
5728
Fluent
FLNT
$102M
| $57K | ﹤0.01% |
3,524
-1,897
| -35% | -$45.4K |
|
5729
Flexsteel Industries
FLXS
$302M
| $57K | ﹤0.01% |
3,801
-1,171
| -24% | -$19.1K |
|
5730
Gran Tierra Energy
GTE
$265M
| $57K | ﹤0.01% |
4,585
+1,471
| +47% | +$21.5K |
|
5731
PUT
LivePerson
LPSN
$21.8M
| $57K | ﹤0.01% |
107
-780
| -88% | -$414K |
|
5732
PUT
Enviri
NVRI
$623M
| $57K | ﹤0.01% |
+3,000
| New | +$63.6K |
|
5733
Neuronetics
STIM
$138M
| $57K | ﹤0.01% |
6,792
-1,890
| -22% | -$20.6K |
|
|
AVEO
5734
CALL
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $57K | ﹤0.01% |
6,750
| – | – |
|
5735
CALL
Douglas Emmett
DEI
$1.98B
| $56K | ﹤0.01% |
1,300
+900
| +225% | +$37.2K |
|
5736
Lee Enterprises
LEE
$172M
| $56K | ﹤0.01% |
2,716
-846
| -24% | -$17.3K |
|
5737
NextCure
NXTC
$16.8M
| $56K | ﹤0.01% |
154
-676
| -81% | -$220K |
|
|
SOHU
5738
CALL
Sohu.com
SOHU
$362M
| $56K | ﹤0.01% |
5,500
-7,300
| -57% | -$85.9K |
|
5739
Twin Disc
TWIN
$329M
| $56K | ﹤0.01% |
5,253
-1,538
| -23% | -$18.2K |
|
5740
PUT
ProShares Ultra Gold
UGL
$650M
| $56K | ﹤0.01% |
4,800
+2,800
| +140% | +$33.2K |
|
|
ASXC
5741
DELISTED
Asensus Surgical, Inc.
ASXC
| $56K | ﹤0.01% |
6,998
-2,136
| -23% | -$29K |
|
|
PBCT
5742
PUT
DELISTED
People's United Financial Inc
PBCT
| $56K | ﹤0.01% |
3,600
-100
| -3% | -$1.56K |
|
|
RNET
5743
DELISTED
RigNet, Inc.
RNET
| $56K | ﹤0.01% |
7,253
-11,541
| -61% | -$97.2K |
|
5744
Arbor Realty Trust
ABR
$964M
| $55K | ﹤0.01% |
4,179
-313,504
| -99% | -$3.92M |
|
5745
AstroNova
ALOT
$225M
| $55K | ﹤0.01% |
3,386
-1,021
| -23% | -$21.3K |
|
5746
Capital Bancorp
CBNK
$608M
| $55K | ﹤0.01% |
4,032
-1,259
| -24% | -$15.9K |
|
5747
PUT
MKS Inc
MKSI
$20.1B
| $55K | ﹤0.01% |
600
-100
| -14% | -$8.26K |
|
|
SRT
5748
DELISTED
Startek Inc.
SRT
| $55K | ﹤0.01% |
8,422
-2,617
| -24% | -$17.7K |
|
|
MTEM
5749
DELISTED
Molecular Templates, Inc.
MTEM
| $55K | ﹤0.01% |
561
-171
| -23% | -$15.9K |
|
|
GCAP
5750
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $55K | ﹤0.01% |
10,572
-6,315
| -37% | -$29.5K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.